Related references
Note: Only part of the references are listed.Quick and Mild Isolation of Intact Lysosomes Using Magnetic-Plasmonic Hybrid Nanoparticles
The Son Le et al.
ACS NANO (2022)
Cyclophilin A Impairs Efferocytosis and Accelerates Atherosclerosis by Overexpressing CD 47 and Down-Regulating Calreticulin
Vinitha Anandan et al.
CELLS (2021)
Hyperglycemia Induces Trained Immunity in Macrophages and Their Precursors and Promotes Atherosclerosis
Laurienne Edgar et al.
CIRCULATION (2021)
Resolvin D1 promotes the targeting and clearance of necroptotic cells
Brennan D. Gerlach et al.
CELL DEATH AND DIFFERENTIATION (2020)
Macrophages in Atherosclerosis Regression
Tessa J. Barrett
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)
Macrophage Metabolism of Apoptotic Cell-Derived Arginine Promotes Continual Efferocytosis and Resolution of Injury
Arif Yurdagul et al.
CELL METABOLISM (2020)
HACE1 Prevents Lung Carcinogenesis via Inhibition of RAC-Family GTPases
Melanie Kogler et al.
CANCER RESEARCH (2020)
Prevention of aortic dissection and aneurysm via an ALDH2-mediated switch in vascular smooth muscle cell phenotype
Kehui Yang et al.
EUROPEAN HEART JOURNAL (2020)
Macrophages Use Distinct Actin Regulators to Switch Engulfment Strategies and Ensure Phagocytic Plasticity In Vivo
Andrew J. Davidson et al.
CELL REPORTS (2020)
Coordinated Ras and Rac Activity Shapes Macropinocytic Cups and Enables Phagocytosis of Geometrically Diverse Bacteria
Catherine M. Buckley et al.
CURRENT BIOLOGY (2020)
Double-edged sword of ALDH2 mutations: one polymorphism can both benefit and harm the cardiovascular system
Francesca Bartoli-Leonard et al.
EUROPEAN HEART JOURNAL (2020)
Single-cell RNA sequencing uncovers heterogenous transcriptional signatures in macrophages during efferocytosis
Connor Lantz et al.
SCIENTIFIC REPORTS (2020)
Efferocytosis in health and disease
Amanda C. Doran et al.
NATURE REVIEWS IMMUNOLOGY (2020)
Dominant activating RAC2 mutation with lymphopenia, immunodeficiency, and cytoskeletal defects
Amy P. Hsu et al.
BLOOD (2019)
Cyclin-dependent kinase inhibitor 2B regulates efferocytosis and atherosclerosis (vol 124, pg 1083, 2014)
Yoko Kojima et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Conventional and genetic evidence on alcohol and vascular disease aetiology: a prospective study of 500 000 men and women in China
Iona Y. Millwood et al.
LANCET (2019)
RPEL-family rhoGAPs link Rac/Cdc42 GTP loading to G-actin availability
Jessica Diring et al.
NATURE CELL BIOLOGY (2019)
Acetaldehyde dehydrogenase 2 interactions with LDLR and AMPK regulate foam cell formation
Shanshan Zhong et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Consideration of Sex Differences in Design and Reporting of Experimental Arterial Pathology Studies-Statement From ATVB Council
Peggy Robinet et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
Sex differences in the formation of atherosclerosis lesion in apoE-/-mice and the effect of 17ß-estrodiol on protein S-nitrosylation
Guangwei Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Lysosomal Cholesterol Hydrolysis Couples Efferocytosis to Anti-Inflammatory Oxysterol Production
Manon Viaud et al.
CIRCULATION RESEARCH (2018)
Aldehyde dehydrogenase 2 Glu504Lys variant predicts a worse prognosis of acute coronary syndrome patients
Chang Pan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2018)
Regulation of macrophage immunometabolism in atherosclerosis
Graeme J. Koelwyn et al.
NATURE IMMUNOLOGY (2018)
Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice
Xuchu Que et al.
NATURE (2018)
Regulatory T Cells Promote Macrophage Efferocytosis during Inflammation Resolution
Jonathan D. Proto et al.
IMMUNITY (2018)
Interferon Regulatory Factor 5 Controls Necrotic Core Formation in Atherosclerotic Lesions by Impairing Efferocytosis
Anusha N. Seneviratne et al.
CIRCULATION (2017)
Recommendation on Design, Execution, and Reporting of Animal Atherosclerosis Studies A Scientific Statement From the American Heart Association
Alan Daugherty et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2017)
Atherosclerosis Successes, Surprises, and Future Challenges
Peter Libby et al.
CIRCULATION RESEARCH (2016)
CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis
Yoko Kojima et al.
NATURE (2016)
Aldehyde dehydrogenase 2 inhibits inflammatory response and regulates atherosclerotic plaque
Chang Pan et al.
ONCOTARGET (2016)
The Pallbearer E3 Ligase Promotes Actin Remodeling via RAC in Efferocytosis by Degrading the Ribosomal Protein S6
Hui Xiao et al.
DEVELOPMENTAL CELL (2015)
Macrophage SR-BI mediates efferocytosis via Src/PI3K/Rac1 signaling and reduces atherosclerotic lesion necrosis
Huan Tao et al.
JOURNAL OF LIPID RESEARCH (2015)
Spatial reconstruction of single-cell gene expression data
Rahul Satija et al.
NATURE BIOTECHNOLOGY (2015)
Rac1 and Rac2 control distinct events during antigen-stimulated mast cell exocytosis
Alicia Baier et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2014)
TARGETING ALDEHYDE DEHYDROGENASE 2: NEW THERAPEUTIC OPPORTUNITIES
Che-Hong Chen et al.
PHYSIOLOGICAL REVIEWS (2014)
Role of aldehyde dehydrogenase 2 Glu504lys polymorphism in acute coronary syndrome
Feng Xu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in east Asians
Norihiro Kato et al.
NATURE GENETICS (2011)
Undertaker, a Drosophila Junctophilin, Links Draper-Mediated Phagocytosis and Calcium Homeostasis
Leigh Cuttell et al.
CELL (2008)
Isoform-specific membrane targeting mechanism of Rac during FcγR-mediated phagocytosis:: Positive charge-dependent and independent targeting mechanism of Rac to the phagosome
T Ueyama et al.
JOURNAL OF IMMUNOLOGY (2005)
Cdc42, Rac1, and Rac2 display distinct patterns of activation during phagocytosis
AD Hoppe et al.
MOLECULAR BIOLOGY OF THE CELL (2004)
Share Paper
